Attached files

file filename
EX-32.2 - EXHIBIT 32.2 - Universal Resourcesv328258_ex32-2.htm
EXCEL - IDEA: XBRL DOCUMENT - Universal ResourcesFinancial_Report.xls
10-K - FORM 10-K - Universal Resourcesv328258_10k.htm
XML - IDEA: XBRL DOCUMENT - Universal ResourcesR5.htm
XML - IDEA: XBRL DOCUMENT - Universal ResourcesR2.htm
XML - IDEA: XBRL DOCUMENT - Universal ResourcesR3.htm
XML - IDEA: XBRL DOCUMENT - Universal ResourcesR4.htm
XML - IDEA: XBRL DOCUMENT - Universal ResourcesR6.htm
XML - IDEA: XBRL DOCUMENT - Universal ResourcesR9.htm
XML - IDEA: XBRL DOCUMENT - Universal ResourcesR8.htm
XML - IDEA: XBRL DOCUMENT - Universal ResourcesR1.htm
XML - IDEA: XBRL DOCUMENT - Universal ResourcesR10.htm
XML - IDEA: XBRL DOCUMENT - Universal ResourcesR12.htm
XML - IDEA: XBRL DOCUMENT - Universal ResourcesR11.htm
EX-31.1 - EXHIBIT 31.1 - Universal Resourcesv328258_ex31-1.htm
EX-32.1 - EXHIBIT 32.1 - Universal Resourcesv328258_ex32-1.htm
EX-31.2 - EXHIBIT 31.2 - Universal Resourcesv328258_ex31-2.htm
Organization of the Company and Significant Accounting Principles
12 Months Ended
Mar. 31, 2012
Accounting Policies [Abstract]  
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]
1.Organization of the Company and Significant Accounting Principles


Global Immune Technologies, Inc. (“the Company”) (formerly Secureview Systems, Inc.) was incorporated in 1985 as a British Columbia corporation. During the fiscal year ended in 2007, the Company re-domiciled to the State of Wyoming. Its business office is located in Sydney Mines, Nova Scotia. The Company is considered a public shell company, with administrative expenses being its only operations.


The Company is considered a development stage company in accordance with the Statement of Financial Accounting Standards No. 7, “Accounting and Reporting for Development Stage Enterprises” (codified in ASC Topic 915, “Development Stage Entities”).


1     Use of Estimates- The preparation of the consolidated financial statements in conformity with generally accepted accounting principles requires management to make reasonable estimates and assumptions that affect the reported amounts of the assets and liabilities and disclosure of contingent assets and liabilities and the reported amounts of revenues and expenses at the date of the financial statements and for the period they include. Actual results may differ from these estimates.


Income taxes- The Company accounts for income taxes in accordance with generally accepted accounting principles which require an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed annually for differences between financial statement and income tax bases of assets and liabilities that will result in taxable income or deductible expenses in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred tax assets and liabilities to the amount expected to be realized. Income tax expense is the tax payable or refundable for the period adjusted for the change during the period in deferred tax assets and liabilities.


The Company follows the accounting requirements associated with uncertainty in income taxes using the provisions of Financial Accounting Standards Board (FASB) ASC 740, Income Taxes. Using that guidance, tax positions initially need to be recognized in the financial statements when it is more likely than not the positions will be sustained upon examination by the tax authorities. It also provides guidance for derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. As of March 31, 2012 and March 31, 2011, the Company has no uncertain tax positions that qualify for either recognition or disclosure in the financial statements. All tax returns from fiscal years 2008 to 2011 are subject to IRS audit.


Global Immune Technologies, Inc. is a Development Stage Company emerging as a holding company of an American-based food distribution company serving direct delivery to the customer at their homes. The food items are sold by telemarketing to the customer and delivered by our own trucks to homes on a scheduled basis. Customers can choose their new order items via the Internet. Items are packed in individual portions at our food processing plants and frozen for freshness. We offer meat, chicken and seafood as well as other food products. These other items are name brand canned and jarred foods like Mott’s Apple Sauce, Dole Pineapple, Jiff peanut butter, tinned tuna fish & salmon and the like.